home
FASENRA® (benralizumab) is an add-on maintenance treatment for patients 6 and older who are diagnosed with severe eosinophilic asthma.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 45.784 |
| 2025-03 | 47.193 |
| 2025-04 | 55.157 |
| Source | Traffic Share |
|---|---|
| search | 56.23% |
| direct | 30.54% |
| paid referrals | 7.25% |
| referrals | 4.29% |
| social | 1.61% |
| 0.08% |
| Region | Percentage |
|---|---|
| United States | 96.64% |
| United Kingdom | 1.71% |
| India | 1.65% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| symptems-dry eye excess seliva wheze when i exhale | 10 | 100 | $0.00 |
| pulmonologist near me | 2,537 | 25,370 | $6.52 |
| shortness of breath symptoms | 598 | 5,980 | $3.02 |
| always tired no energy shortness of breath | 18 | 180 | $0.00 |
| childhood asthma drug | 6 | 60 | $0.00 |